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Abstract:
Background:Hmox1 plays an important role in the regulation of mitochondrial bioenergetics and function by
regulating cellular heme-derived CO and bilirubin. Previous studies have demonstrated that global disruption
of HO-1 in humans and mice resulted in severe organ dysfunction.
Methods:We investigated the potential role of adipose-speciﬁc-HO-1 genetic ablation on adipose tissue func-
tion, mitochondrial quality control and energy expenditure by generating an adipo-HO-1 knockout mouse
model (Adipo-HO-1−/−) and, in vitro, adipocyte cells in which HO activity was inhibited. Adiposity, signaling
proteins, fasting glucose and oxygen consumption were determined and compared to adipocyte cultures with
depressed levels of both HO-1/HO-2.
Results: Adipo-HO-1−/− female mice exhibited increased adipocyte size, and decreases in the mitochondrial
fusion to ﬁssion ratio, PGC1, and SIRT3. Importantly, ablation of HO-1 in adipose tissue resulted in fat acquir-
ing many properties of visceral fat such as decreases in thermogenic genes including pAMPK and PRDM16.
Deletion of HO-1 in mouse adipose tissue led to complete metabolic dysfunction, an increase in white adipose
tissue, a reduction of beige fat and associated increases in FAS, aP2 and hyperglycemia. Mechanistically, genetic
deletion of HO-1 in adipose tissues decreased the mitochondrial fusion to ﬁssion ratio; disrupted the activity
of the PGC1 transcriptional axis and thermogenic genes both in vitro and in vivo.
Conclusion:Ablation of adipose tissue-HO-1 abridged PGC1 expression promotedmitochondrial dysfunction
and contributed to an increase of pro-inﬂammatory visceral fat and abrogated beige-cell like phenotype.
Keywords: bilirubin, CO, heme oxygenase, Mnf2, PGC1α
DOI: 10.1515/hmbci-2017-0027
Received:May 3, 2017; Accepted: June 23, 2017
Introduction
Obesity is considered a major risk factor for the development of vascular dysfunction, inﬂammation, insulin
resistance andmetabolic syndrome. Chronic obesity and an increase of visceral fat is associated with adipocyte
dysfunction that contributes to an increase in reactive oxygen species (ROS) and changes in adipocyte-derived
paracrine factors [1], [2], [3]. Obesity-mediated development of hyperglycemia suppresses HO-1 levels [4], [5],
[6]. Hyperglycemia is associated with an increase in ROS and peroxynitrite that results [7], [8], [9] in an in-
crease in cellular heme levels [7], [9], [10]. Increased heme levels are essential to increase adipocyte terminal
diﬀerentiation and adipogenesis in vivo [10], [11]. However, an excessive increase in heme in conjunction with
a decrease in HO-1 function may lead the adipocyte to proceed to terminal diﬀerentiation and inﬂammation
[12], [13]. An increase in heme and a reduction in HO-1 levels, as seen in HO-1 deletion, results in a detrimental
AttallahKappas,NaderG. Abraham are the corresponding authors.
©2017, Attallah Kappas andNader G. Abraham et al., published byDeGruyter.
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cellular eﬀect due to increased ROS levels triggered by heme andH2O2, with as a consequence an increase in the
inﬂammatory properties of both monocytes and macrophages [14], [15] and increased adipocyte dysfunction
[16], [17], [18].
Studies in humans and mice show that lack of HO-1 causes rupture of macrophages and tissue inﬂamma-
tion due to exposure of non-metabolized heme released on erythrophagocytosis [19]. The discovery that HO-1
may be a novel target for modulation of the inﬂammatory response [20], [21] and diminished ﬁbrosis [22], has
increased interest in HO-1 signaling pathways.
Adipose tissue function is controlled by several processes including mitochondrial biogenesis, adaptive
thermogenesis, mitochondrial fatty acid oxidation, oxygen consumption and oxidative phosphorylation that
are regulated by PGC-1α [23], [24], [25]. Adipocytes store fat and excess energy, however, beige and brown
adipocytes are regarded as the major source of mitochondrial and thermogenic function to combat obesity and
metabolic syndrome [23], [26]. Several transcriptional factors regulate the levels of signaling molecules that are
involved in the expression of thermogenic and mitochondrial function in beige and visceral fat [23], [25], [26],
[27], [28], [29].
Transduction of HO-1 in mice fed a high fat diet mitigated weight gain and decreased visceral fat content.
Higher levels of HO-1 increased the number of adipocytes of small cell type, which is described as “browning
of the white fat” (or thermogenic fat). This thermogenic fat is a unique phenotype called beige fat and is distinct
from both white fat and brown fat, increasing adiponectin and sonic hedgehog and decreasing inﬂammatory
cytokines [16].
Administration of an EET agonist, HO-1 inducer inhibited terminal diﬀerentiation and inﬂamed adipogen-
esis, decreased cytokine levels and increased the number of small cell adipocytes or beige cells [17]. Likewise,
PCG-1α expression is induced by exposure to cold [30], [31]. PCG-1α is a major regulator of mitochondrial bio-
genesis and oxidative metabolic pathways and induces mitochondrial and thermogenic genes such as UCP-1.
Similarly, ablating PGC1-α results in reduced capacity for adaptive thermogenesis through activation of beige
fat cells when exposed to cold [32]. Together, this demonstrates that PGC-1α plays an important role in beige
fat cell development and function [33]. Additionally, there is a mitochondrial network function that depends
on signaling molecules and the relationship between mitochondrial fusion and ﬁssion. While mitochondrial
ﬁssion is orchestrated by the dynamin-related protein 1 (DRP1) and the mitochondrial ﬁssion 1 (Fis1) protein
[34], [35], the fusion process is controlled by the autosomal dominant optic atrophy 1 (OPA1) protein, together
with the mitochondrial fusion proteins mitofusion 1 and 2 (Mfn 1 and 2), located on the mitochondrial outer
membrane, [36], [37]. As HO-1/HO-2 are known regulators of mitochondrial integrity and function [38], [39],
[40], [41], we hypothesized that adipose HO-1 gene is essential for increased mitochondrial fusion that may
result in an increase in the beige cell population within adipose tissue or conversion of white adipose function
populations and white adipose function that include expression of PGC1α levels and thermogenic genes.
Materials andmethods
Cell culture and treatment
Pre-adipocytes; 3T3-L1 were maintained and cultured in adipogenic medium as described [12]. Cells were
treated with the HO activity inhibitor, SnMP (2 μM, Tin mesoporphyrin), every 3-days and harvested as de-
scribed [12].
Animals
Adipocyte speciﬁc HO-1 null mice were generated by breeding AdipoQCre and Hmox1ﬂ/ﬂ mice on a C57BL/6
genetic background.Mice homozygous for ﬂoxedHmox1 carry at least one allele for cre recombinase under the
adiponectin promoter were used. Subsequently the generated mice were knockout for HO-1 in adipose tissue.
Mice were fed a normal chow diet for 30 weeks and matched with age-matched wild type C57BL/6 mice. In
this study only female mice were used.
Lentiviral vectors under the control of the adipocyte-speciﬁc promoter aP2were constructed using the Lenti-
Max™ system (Lentigen, Baltimore,MA, USA). Lentiviruses (50 μL, 2 × 109 TU/mL in saline) were injected into
the littermate of aP2-HO-1−/− mice by a single intracardiac injection. Two weeks later a second injection was
completed (75 μL 1 × 109 TU/mL in tail vein) as previously described [16]. Mice were divided into two groups
(n = 6 per group): adipo-HO-1+/+ and adipo-HO-1−/− lenti-aP2-HO-1 at 30 weeks of age. Mice were weighed
every week, blood glucose was determined [16], [18], [42]. All experimental protocols were performed follow-
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ing an IACUC of New YorkMedical College and a animal protocols were approved by the Institutional Animal
Care and the University of Mississippi Medical Center approved protocol in accordance with theNIH Guide for
the Care and Use of Laboratory Animals.
RNA/real-timepolymerase chain reaction (PCR) of thermogenic andmitochondrial genes
Total RNA was extracted from 3T3 cells using TRIzol® (Ambion, Austin, TX, USA) and from frozen adi-
pose tissues by RNeasy® Lipid Tissue (Qiagen), as per instructions provided by the manufacturers. Speciﬁc
TaqMan® Gene Expression Assays probes for mouse HO-1, PGC1α, COX-IV (cytochrome c oxidase subunit-IV),
adiponectin, TNFα, and other signaling RNA were determined as previously described [42], [43].
Western blot analysis
Frozen mouse adipose tissues were ground under liquid nitrogen and suspended in homogenization buﬀer
(mmol/L: 10 phosphate buﬀer, 250 sucrose, 1.0 EDTA, 0.1 PMSF, and 0.1% v/v tergitol, pH 7.5). For in vitro
Western blot analysis pelleted cells were lysed andHO-1 and other signaling proteins weremeasured [12], [44].
Morphological adipose tissue evaluation
Adipose tissue was prepared for morphological analysis. Samples were cut using a microtome (5 μm thick),
mounted on D-polylisinated glass slides, deparaﬀinizated in xylene and either stained with hematoxylin and
eosin for the evaluation of adipocyte size [16].
Statistical analysis
Data are expressed as means ± standard error of mean (SEM). Signiﬁcance of diﬀerence in mean values was
determined using one-way analysis of variance followed by the Newman-Keul’s post hoc test. p < 0.05 was
considered to be signiﬁcant.
Results
HOactivity inhibition reduces PGC1α, andmitochondrial signaling in cell culture
Western blot data demonstrate signiﬁcant (p < 0.05) inhibition of PGC1α protein levels with SnMP-treated cells
compared to WT cells. Furthermore, protein expression of SIRT1 and SIRT3 was signiﬁcantly (p < 0.05) de-
creased in the SnMP treated cells as compared to WT cells (Figure 1A–D).
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Figure 1: Eﬀect of inhibition of HO activity by SnMP on WT and 3T3-L1 adipocytes cells on gene expression related to
mitochondrial biogenesis and dynamics.
(A) Representative Western blots of PGC1α, SIRT1, SIRT3, Mfn1and Mfn2 proteins. Densitometric analyses of (B) PGC1α,
(C) SIRT1, (D) SIRT3, (E) Mfn1 and (F) Mfn2 proteins. mRNA expression of (G) Fis1, (H) COX-I and (I) FGF21 in WT and
3T3-L1-derived adipocyte cells treated with SnMP. Results are mean ± SE, n = 4, *p < 0.05 vs. WT.
To examine whether inhibition of HO activity can modulate the mitochondrial fusion-to-ﬁssion ratio we
treated adipocytes with SnMP. RT-PCR data show increased mRNA expression levels of ﬁssion related Fis1
as compared to WT cells (p < 0.05) (Figure 1G). Interestingly the mitofusion related Mfn1 and Mfn2 protein
expression levels were signiﬁcantly (p < 0.05) decreased in WT cells treated with SnMP as compared to WT
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cells alone (Figure 1A, E and F). The mRNA expression levels of COX-I and FGF21 were signiﬁcantly (p < 0.05)
decreased in the SnMP treated cells as compared to WT cells. (Figure 1H and I).
HOactivity inhibition increases expression of adipogenicmarkers in cell culture
SnMP increased (p < 0.05) the expression of the adipogenic markers Rev-Erb α, PPARy and aP2 (Figure 2).
Western blot analysis demonstrated that SnMP increased the expression levels of Rev-Erbα as compared to
WT cells (Figure 2A and B). Similarly mRNA expression of adipogenic PPARy and aP2 signiﬁcantly (p < 0.05)
increased in adipocyte cells as compared to WT cells (Figure 2C and D) (p < 0.05).
Figure 2: Eﬀect of inhibition of HO activity by SnMP on WT and 3T3-L1 adipocytes cells on adipogenic Rev-Erbα, PPARϒ
and aP2 expression.
(A) Representative Western blots of Rev-Erbα proteins. Densitometric analyses of (B) Rev-Erbα proteins. mRNA expres-
sion of (C) PPARϒ and (D) aP2 in WT and 3T3-L1-derived adipocyte cells treated with SnMP. Results are mean ± SE,
n = 4, *p < 0.05 vs. WT.
HO-1 genetic deletion is a negative regulator andwhite fat expression andbodyweight in femalemice
We created a mouse strain with the speciﬁc deletion of the HO-1 gene using the cre-lox system. At birth, the
Adipo-HO-1−/− mice appeared normal and were indistinguishable from their control littermates. At 30 weeks
of age Adipo-HO-1−/− mice exhibited an 11% increase in body weight compared with age-matched WT mice
(p < 0.05) Figure 3A. By 30 weeks of age Adipo-HO-1−/− mice exhibited increases in epididymal (0.40 ± 0.06
vs. 0.74 ± 0.09; p < 0.05) and visceral fat (0.35 ± 0.04 vs. 0.6 ± 0.07; p < 0.05), suggesting that the increases in fat
may be critical in Adipo-HO-1-null adiposity (Figure 3B and C). Fasting blood glucose levels in HO-1-null mice
were 120.6 ± 2.55 mg/dL compared with 99.5 ± 2.08 mg/dL in WT mice (p < 0.05) (Figure 3D).
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Figure 3: (A) Body weight of 30-week-old female WT and adipocyte speciﬁc HO-1 knockout mice (B) epydidmal fat, and
(C) visceral fat content in mice fed a normal diet (wild-type [WT] and adipocyte speciﬁc knock out (KO) (D) fasting blood
glucose in mice fed a normal diet WT and KO. n = 4–6; *p < 0.05 vs. WT.
Expression of RNAand signaling protein inAdipo-HO-1−/− femalemice
Adipo-HO-1−/− mice display decreases in HO-1 at the levels of both mRNA and protein (p < 0.001) (Figure
4A, B, and C). To determine whether adipocyte speciﬁc knockout aﬀected HO-2 levels, we performed real time
(RT)-PCR analysis for HO-2 RNA levels which clearly demonstrated that HO-1 deletion was not associated
with an increase in HO-2 expression when compared to WT mice (Figure 4D).
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Figure 4: RT-PCR and Western blots analyses of adipose tissue of mice: (A) relative HO-1 mRNA expression with indi-
vidual WT as well as in KO mice, (B) WBs showed protein expression of HO-1 with adipose tissue in WT and KO mice,
(C) HO-1 WBs densitometry analyses in WT and KO mice, (D) relative HO-2 mRNA expression, (E) adipocytes size, (F)
measurements of adipocytes size in adipose tissue of WT and KO mice; n = 4–6, *p < 0.05 vs. WT.
Adipo-HO-1 genedeletion decreases oxygen consumption in femalemice
We examined the eﬀect of adipocyte speciﬁc deletion of HO-1 on both O2 consumption and the ratio of CO2/O2
in mice. As expected, HO-1−/− mice displayed a decrease in VO2 consumption (p < 0.05) (Figure 5A). However,
control animals had a signiﬁcant (p < 0.05) increase in oxygen consumption with a concomitant lowering of
VCO2/VO2 (Figure 5A and B). Importantly protein expression of COX-IV was signiﬁcantly (p < 0.05) decreased
in the HO-1 knockout mice as compared to WT mice (Figure 5C and D).
Figure 5: Eﬀect of HO-1 deletion on oxygen consumption and respiratory quotient (RQ).
(A) Mouse respiratory oxygen consumption, (B) respiratory quotient (RQ). Representative Western blots of COX-IV pro-
teins (C) and (D) densitometric analyses of COX-IV in adipose tissue of WT and KO mice; n = 4–6, *p < 0.05 vs. WT.
Adipo-HO-1 genedeletion reduces thermogenicmitochondrial fusion andﬁssion genes in femalemice
Western blot analysis clearly demonstrated a decrease (p < 0.05) in the protein expression of PGC-1α in
Adipo-HO-1−/− mice compared with those in age-matched WT mice (Figure 6A and B). SIRT1 was signiﬁ-
cantly (p < 0.05) decreased in HO-1-null mice at both the mRNA and protein expression levels compared to
WT mice (Figure 6A and C). SIRT3 expression was decreased with HO-1 ablation (p < 0.05), similarly SIRT1
decreased with HO-1 deletion in adipose tissue of mice (p < 0.05) (Figure 6A and D).
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Figure 6: Eﬀect of HO-1 deletion on PGC1α, SIRT1, SIRT3, Mfn1 and Mfn2 proteins. (A) Representative Western blots of
PGC1α, SIRT1, SIRT3, Mfn1and Mfn2 proteins. Densitometric analyses of (B) PGC1α, (C) SIRT1, (D) SIRT3, (E) Mfn1 and
(F) Mfn2 proteins. Hematoxylin-eosin staining depicts adipocyte size of WT (G), and (H) adipo-HO-1 null, (I) adipocyte
count. RT-PCR analyses represents mRNA expression of (J) OPA1, (K) Fis1 and (L) DRP1 in mice in adipose tissue of WT
and KO mice; n = 4, *p < 0.05 vs. WT.
The expression of mitochondrial fusion related to proteins in HO-1 null mice was signiﬁcantly (p < 0.05)
reduced as compared to WT mice during WB analysis. The adipose tissue of HO-1 null mice exhibited signiﬁ-
cantly (p < 0.05) decreased ofmitofusion relatedMfn1 andMfn2protein expression aswell asmRNAexpression
(Figure 6A, E and F). We examined the adipocyte size by hematoxylin-eosin inWT andAdipo-HO-1−/− in mice
adipose tissue. HO-1 null mice showed signiﬁcant (p < 0.05) increase in adipocyte size compared to WT mice
(Figure 6G, H and I).
However, RT-PCR results demonstrated that there was signiﬁcantly increased of mitoﬁssion related Fis1
mRNA expression levels (Figure 6K). The fusion related OPA 1 mRNA was signiﬁcantly (p < 0.05) reduced in
HO-1 null mice (Figure 6J). There was no eﬀect on DRP1 mRNA expression (Figure 6L).
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E昀�fect of Adipo-HO1-Null onAMPKand signaling in adipose tissues
The protein content and phosphorylation of AMPK were reduced (p < 0.05) in adipose tissue from Adipose
HO-1 knockout mice compared to WT (Figure 7A and B). Densitometry analysis did not show a signiﬁcant
decrease in the expression of phosphorylation insulin receptors of Adipo-HO-1-null mice as compared to WT
mice (Figure 7A, C and D). mRNA levels of adiponectin in Adipo-HO-1-null mice were signiﬁcantly (p < 0.05)
lower than those in age-matched WT mice (Figure 7E). PRDM16 is involved in the development and function
of classical brown and beige adipocytes. Our study found a signiﬁcant decrease (p < 0.05) in PRDM16 mRNA
expression in Adipo-HO-1-null mice as compared to WT mice (Figure 7F).
Figure 7: (A) Western blots and densitometry analyses of (B) pAMPK, (C) pAKT, (D) IRp972 and (E) IRp1146. mRNA
expression of (E) adiponectin and (F) PRDM16 in adipose tissue of WT and KO mice; *p < 0.05 vs. WT.
Adipo-HO-1−/−mice display increased expression of adipogenic and infllammatorymarkers
We showed a signiﬁcant increase (p < 0.05) in Rev-Erbα expression in Adipo-HO-1-null mice compared to WT
control mice (Figure 8A and B). Further, Adipo-HO-1 deletion results in a signiﬁcant increase in the protein
expression of FAS (p < 0.05) compared with age-matched WT mice (Figure 8A and C). Similarly, Adipo-HO-
1-deletion was associated with an increase in the expression of adipogenic aP2 protein levels (p < 0.05) (Figure
8A and D).
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Figure 8: (A) Western blots and densitometry analyses of (B) Rev-Erbα, (C) FAS, (C) aP2 and mRNA expression of (E)
TNFα and (F) IL-6 in adipose tissue of WT and KO mice; *p < 0.05 vs. WT.
Obesity is frequently accompanied by systemic inﬂammation and this was examined in the current study
by measuring proinﬂammatory markers relative mRNA expression levels. The HO-1-null mice had increased
(p < 0.05) levels of inﬂammatory cytokines in adipose tissue compared with age-matched WT mice seen in
(Figure 8E and F). Our study reports signiﬁcant increases (p < 0.05) in TNFα and IL1β mRNA expression in
Adipo-HO-1-null mice as compared to WT mice (Figure 8E and F).
Adipose tissues speciﬁc ofHO-1 using lentiviral ap2 promoter rescuesAdipo-HO-1−/− phenotype in
femalemice
We examined adipocyte size in both HO-1−/− mice and in WT littermates using hematoxylin-eosin and com-
pared adipo-HO-1−/− transfected with lenti-aP2-HO-1 mice (Figure 9). Adipo-HO-1−/− mice displayed an in-
crease (p < 0.05) in adipocyte cell size (hypertrophy) compared to WT mice adipocyte (Figure 9A, B and D).
Adipocyte hypertrophy seen in Adipo-HO-1−/− were rescued by administration of lenti-aP2- HO-1 viral vec-
tor (Figure 9C and D). Further, signaling of mitochondrial and thermogenic genes in Adipo-HO-1−/− was re-
stored toWT adipose levels following transfection with lenti-aP2-HO-1. Our study found a signiﬁcant decrease
(p < 0.05) in PRDM16 mRNA expression in Adipo-HO-1-null mice as compared to WT mice, which was re-
versed by administration of lenti-aP2- HO-1 viral vector (Figure 9E). Similarly the adipose tissue of HO-1 null
mice exhibited signiﬁcantly (p < 0.05) decreased levels of HO-1, PGC-1α andmitofusion relatedMfn1 andMfn2
protein expression and which were rescued by administration of lenti-aP2- HO-1 viral vector (Figure 9F–J).
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Figure 9: Hematoxylin-eosin depicts adipocyte size of WT (A), adipo-HO-1null (B) and (C) adipo-HO-1 over expressed
(D) adipocyte measurements in adipose tissue of WT, KO and HO-1 overexpressed mice; n = 10–15. (E) mRNA expression
of PRDM16, (F) Western blots and densitometry analyses of (G) PGC1α, (H) HO-1, (I) Mfn1, (J) Mfn2 in adipose tissue of
WT, KO and HO-1 overexpressed mice; n = 4, *p < 0.05 vs. WT, #p < 0.05 vs. KO.
Discussion
In the present report, we constructed a mouse model with the speciﬁc ablation of adipose HO-1 that aﬀect vis-
ceral fat expansion and inﬂammation. As a result, adipose speciﬁc HO-1−/− animals exhibited a signiﬁcant re-
duction in mitochondrial integrity genes, thermogenic gene expression and O2 consumption. Adipo-HO-1
−/−
developed enlargement of visceral fat and adipocyte hypertrophy that was associated with hyperglycemia.
Importantly, deletion of HO-1 resulted in a marked decrease in PGC-1α levels and important genes that be-
long to beige and brown adipocytes [30], [45]. Reduction of PGC-1α levels is associated with insulin resistance
and hyperglycemia [46] and a decrease of mitochondrial oxidation phosphorylation and metabolic regulators
[45], [47]. PGC-1α gene expression enhanced the changes to brown-like fat from white fat [30]. Additionally,
Adipo-HO-1−/− displays a reduction of PRDM16, a major player in browning adipose tissue. These results are
in agreement with the ﬁndings that the ablation of PRMD16 in mice increased visceral fat and inhibited ther-
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mogenic genes [48]. PRDM16 is necessary for brown fat phenotype and is an important factor in the conversion
of WAT to beige fat under beta adrenergic stimulation [49].
PRDM16 activates the expression of thermogenic and mitochondrial genes [49]. This allows the beige fat to
have increased mitochondrial content and uncoupled respiration, resulting in thermogenesis.
WAT can be transformed into thermogenic adipose tissue or “beige” fat. Both classic thermogenic tissue
(BAT) and inducible thermogenic tissue (beige fat) increase heat production through an uncoupling oxidative
metabolism from ATP production [50]. The leak in the proton gradient caused by the UCP-1 means that fuel
oxidation can be accelerated and is not limited by saturation concentration of ATP and causes heat production
[51]. Similarly, levels of AMPK were decreased on Adipo-HO-1−/− mice. AMPK regulation of mitochondrial
function and white to beige like cells [29] and reprograms adipocyte cells diﬀerentiation to healthy adipocytes
to release adiponectin [16], [44], [52].
Our data showed that the adipocyteHO-1−/− phenotype can be rescued by lentiviral-aP2-HO-1,with the re-
versal of visceral fat adipocyte size to smaller healthy adipocytes. We previously showed that targeting adipose
tissue using adipocyte tissue speciﬁc HO-1 (aP2-HO-1) decreases pro-inﬂammatory adipokines and adipocyte
cell size that produces adiponectin, i.e. beige-like cells [16]. Our present data shows thatHO-1 deletion abridged
mitochondrial dynamics, biogenesis in female mice by the downregulation of mitochondrial fusion over ﬁssion
and increased adipocyte hypertrophy.
Essentially balanced mitochondrial dynamics is important for the maintenance of mitochondrial health,
function and energy generation [39], [53]. Concomitantly inhibition of HO activity reduces mitochondrial qual-
ity control by inhibition ofmitochondrial fusionmediatorMfn1,Mfn2 andOpa1 but activation ofmitochondrial
ﬁssion mediator Fis1 [42], [43]. Hence, our study oﬀers a portal on the unique role of HO-1 in adipose tissue by
its ability to maintain mitochondrial quality and biogenesis. HO-1 expression appears to aﬀect adipocyte func-
tion through the regulation of heme bioavailability. This comprises heme containing denatured proteins, gen-
eration of the bioactive metabolites carbon monoxide and biliverdin, inhibiting cellular buildup of free heme,
and preventing free radical accumulation and mitochondrial dysfunction [2], [54]. Recently, we demonstrated
that EET-agaonist-mediated HO-1 induction ameliorates progressiono f cardiomyopathy [58].
Spiegelman’s group elegantly showed that PGC1α is a regulator of ALA-synthetase, (ALAS) the ﬁrst and
rate limiting enzyme in heme biosynthesis [55]. An increase of heme turnover following an increase of ALAS
is associated with a reduction of adiposity, increased mitochondrial function and adipocyte function [56], [57].
These results are in agreement with this report that HO-1 deletion results in a decrease in heme turnover and
PGC1α, the latter is essential to restore mitochondrial integrity and increase beige like cells. In contrast, induc-
tion of HO-1 increases heme turnover, increases PGC1α, ALAS, while increasing both bilirubin and CO which
improve adipose and vascular function via the reduction of ROS and an increase in antioxidant molecules,
bilirubin and MnSOD (reviewed in [2], [13]. It can be concluded from this study that HO-1 induction is asso-
ciated with the reprogramming of adipocytes in white adipose tissue to acquire characteristic of beige fat cell.
Consequently, the activation of HO-1 signaling pathway may lead to identiﬁcation of new therapeutic target
that address the metabolic dysfunction associated with the progressive nature of the metabolic syndrome by
restoring beige like adipocyte cell population in adipose tissues that can be using for cell therapy (Figure 10).
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Figure 10: Schematic description showed that HO-1 gene ablation leads to an increase of adipogenic FAS, MEST and aP2
expression, in adipose tissue which is responsible for elevated adipocyte expansion, hypertrophy and releases inﬂamma-
tory adipokines while decreasing PGC1.
Targeting adipose tissues-speciﬁc HO-1 expression increases mitofusion over mitoﬁssion in adipocyte culture as well as
adipose tissue of mice. It may be concluded that HO-1 is important decreases excessive heme that result in stimulation of
thermogenic genes PGC1α, PRDM16 and adiponectin. Over all HO-1 ablation leads to an increase of white fat over beige
like phenotype that is prevented by adipo-aP2-HO-1 expression.
In summary, HO-1 deletion abridged mitochondrial biogenesis and function by downregulation of PGCα,
SIRT1 Mfn1, Mfn2 and Opa1 but activation of mitochondrial ﬁssion mediator Fis1. In contrast lenti-aP2-HO-1
reversed the detrimental eﬀects of HO-1 deletion. HO-1 increased as did HO activity thereby decreasing heme
levels and increasing PGC-1α levels with a subsequent decrease in adipogenesis and obesity. The increase in
heme turnover enhanced adipocyte diﬀerentiation and produced smaller healthy adipocytes [17]. This when
considered with the adverse eﬀect of obesity on both HO-1 and PGC-1α in adiposity and the production of
healthy beige adipocytes. This study provided valuable insights into therapeutic approaches to control obesity
and to insure healthy adipocytes. The importance of the symbiotic relationship between HO-1 and PGC1α also
oﬀers a potential therapeutic sight for intervention in the control of obesity andmetabolic syndrome to increase
beige-fat like population within adipose tissue.
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